We next investigated whether the canonical PINK1/Parkin pathway played a role in ovarian cancer development and chemoresistance, but low levels of Parkin in ovarian cancer were observed via sample data retrieved from The Human Protein Atlas (Fig. S4A). Here, PRKN is linked to ovarian carcinoma.